ZYLET Drug Patent Profile
✉ Email this page to a colleague
When do Zylet patents expire, and what generic alternatives are available?
Zylet is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in ZYLET is loteprednol etabonate; tobramycin. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loteprednol etabonate; tobramycin profile page.
Summary for ZYLET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZYLET |
What excipients (inactive ingredients) are in ZYLET? | ZYLET excipients list |
DailyMed Link: | ZYLET at DailyMed |
Pharmacology for ZYLET
Drug Class | Aminoglycoside Antibacterial Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ZYLET
US Patents and Regulatory Information for ZYLET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZYLET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZYLET
See the table below for patents covering ZYLET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 275749 | STABLE AQUEOUS SUSPENSIONS OF WATER-INSOLUBLE STEROIDS USING A NONIONIC POLYMER AND A NONIONIC SURFACTANT | ⤷ Try a Trial |
Canada | 2174550 | SUSPENSION D'ETABONATE DE LOTEPREDNOL (SUSPENSION OF LOTEPREDNOL ETABONATE) | ⤷ Try a Trial |
Japan | S5745200 | ANTI-INFLAMMATORY STEROID AND PHARMACOLOGICAL COMPOSITION CONTAINING THE SAME | ⤷ Try a Trial |
Austria | 217523 | ⤷ Try a Trial | |
Sweden | 449106 | STEROID MED ANTI-INFLAMMATORISK VERKAN SAMT KOMPOSITION INNEHALLANDE DENNA | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |